Similar Papers

Paper Title
Journal
Date
Author
AB0559 EFFICACY AND SAFETY OF RISANKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS AFTER INADEQUATE RESPONSE OR INTOLERANCE TO DMARDs: 24-WEEK RESULTS FROM THE PHASE 3, RANDOMIZED, DOUBLE-BLIND KEEPsAKE 1 TRIAL
L E Kristensen ... D White
Annals of the Rheumatic Diseases | VOL. 80
L E Kristensen, et. al.L E Kristensen ... D White
19 May 2021
32244 Impact of risankizumab on achieving minimal clinically important differences in patient-reported disease activity, fatigue, and pain among patients with active psoriatic arthritis: Analysis of 2 phase 3 clinical trials
Lars Erik Kristensen ... Ahmed Soliman
Journal of the American Academy of Dermatology | VOL. 87
Lars Erik Kristensen, et. al.Lars Erik Kristensen ... Ahmed Soliman
01 Sep 2022
Long-Term Efficacy and Safety of Risankizumab for csDMARD-IR Patients With Active Psoriatic Arthritis: 196-Week Results From the KEEPsAKE 1 Trial
Frank Behrens ... Lily Glotfelty
SKIN The Journal of Cutaneous Medicine | VOL. 8
Frank Behrens, et. al.Frank Behrens ... Lily Glotfelty
18 Nov 2024
The effect of risankizumab on achieving minimal clinically important differences in patient-reported outcomes in patients with psoriatic arthritis: results from KEEPsAKE 1 and 2.
L.E Kristensen ... A Eldred
Journal of the European Academy of Dermatology and Venereology | VOL. 36
L.E Kristensen, et. al.L.E Kristensen ... A Eldred
12 Oct 2022
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
Systematic literature review and meta-analysis informing the EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the rheumatic diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
20 Dec 2024
2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer
Eden Sebbag ... Jacques-Eric Gottenberg
Annals of the Rheumatic Diseases | VOL. -
Eden Sebbag, et. al.Eden Sebbag ... Jacques-Eric Gottenberg
19 Dec 2024
Contents
-
Annals of the Rheumatic Diseases | VOL. 83
--
01 Dec 2024
Expert consensus recommendations for the diagnosis and treatment of chronic non-bacterial osteitis (CNO) in adults
Elizabeth M Winter ... Anne T Leerling
Annals of the Rheumatic Diseases | VOL. -
Elizabeth M Winter, et. al.Elizabeth M Winter ... Anne T Leerling
28 Nov 2024
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.